Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults

Bonten MJ;Huijts SM;Bolkenbaas M;Webber C;Patterson S;Gault S;van Werkhoven CH;van Deursen AM;Sanders EA;Verheij TJ;Patton M;McDonough A;Moradoghli-Haftvani A;Smith H;Mellelieu T;Pride MW;Crowther G;Schmoele-Thoma B;Scott DA;Jansen KU;Lobatto R;Oosterman B;Visser N;Caspers E;Smorenburg A;Emini EA;Gruber WC;Grobbee DE;;
The New England journal of medicine 2015 Vol. 372 pp. -
280
mj2015thepolysaccharide

Abstract

Among older adults, PCV13 was effective in preventing vaccine-type pneumococcal, bacteremic, and nonbacteremic community-acquired pneumonia and vaccine-type invasive pneumococcal disease but not in preventing community-acquired pneumonia from any cause. (Funded by Pfizer; CAPITA ClinicalTrials.gov n …

Citation

ID: 269974
Ref Key: mj2015thepolysaccharide
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
269974
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet